Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct 19;45(5):1454-1462.
doi: 10.3906/kim-2104-13. eCollection 2021.

Antiinfective properties of ursolic acid-loaded chitosan nanoparticles against Staphylococcus aureus

Affiliations

Antiinfective properties of ursolic acid-loaded chitosan nanoparticles against Staphylococcus aureus

Fatemeh Ghasemzadeh et al. Turk J Chem. .

Abstract

The present study aimed to synthesize ursolic acid-loaded chitosan nanoparticles (UA-Ch-NPs) as an antiinfective agent against 21 Staphylococcus aureus isolates. The UA-Ch-NPs were synthesized by a simple method and then characterized by TEM, FTIR, DLS-zeta potential, and XRD analyses. According to the characterization results, highly dispersed spherical nanoparticles with a mean diameter of 258 nm and a zeta potential of + 40.1 mV were developed. The antibacterial properties of UA-Ch-NPs were investigated and their inhibitory effect on biofilm formation was demonstrated by AFM. Finally, the expression levels of icaA and icaD were measured using real-time PCR. Results indicated that the minimum inhibitory concentration (MIC) of UA and UA-Ch-NPs against S. aureus was 64 and 32 µg/mL, respectively. The treatment of bacterial cells with UA-Ch-NPs significantly decreased the expression of icaA and icaD genes which are engaged in biofilm formation. Our results indicated that UA-Ch-NPs could be a promising material for antibacterial and antibiofilm applications.

Keywords: biofilm; Staphylococcus aureus bacteria; Ursolic acid-loaded chitosan nanoparticle.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST: none declared

Figures

Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3

Similar articles

Cited by

References

    1. Honda H Krauss MJ Jones JC Olsen MA Warren DK The value of infectious diseases consultation in Staphylococcus aureus bacteremia. The American Journal of Medicine. 2010;123:631–637. - PMC - PubMed
    1. Vasudevan P Nair MKM Annamalai T Venkitanarayanan KS Phenotypic and genotypic characterization of bovine mastitis isolates of Staphylococcus aureus for biofilm formation. Veterinary Microbiology. 2003;92:179–185. - PubMed
    1. Lopez-Garcia S Castaneda-Sanchez JI Jimenez-Arellanes A Dominguez-Lopez L Castro-Mussot ME Macrophage activation by ursolic and oleanolic acids during mycobacterial infection. Molecules. 2015;20:14348–14364. - PMC - PubMed
    1. Nascimento Do Lemos PGG Bizerra TLG Arriaga AMC Ferreira ÂMC DA Antibacterial and antioxidant activities of ursolic acid and derivatives. Molecules. 2014;19:1317–1327. - PMC - PubMed
    1. Kozai K Miyake Y Kohda H Kametaka S Yamasaki K Inhibition of glucosyltransferase from Streptococcus mutans by oleanolic acid and ursolic acid. Caries Research. 1987;21:104–108. - PubMed

LinkOut - more resources